A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular Dysfunction
Trial details
- Registry ID
- NCT04614467
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| A Placebo-Controlled Trial of CLBS16 in Subjects With Coronary Microvascular DysfunctionNCT04614467 | LSTA | Phase 2 | Terminated | 2022-09-28Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |